Compositions and methods for improving payload regulation using activated T-cell nuclear factor (nfat) response elements
CO20260008620A2Pending Publication Date: 2026-06-30OBSIDIAN THERAPEUTICS INC
Patent Information
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- OBSIDIAN THERAPEUTICS INC
- Filing Date
- 2026-06-11
- Publication Date
- 2026-06-30
Abstract
Nucleic acid constructs comprising one or more activated T-cell nuclear factor (ATNF) response elements and an expressible nucleic acid sequence encoding a first manipulated polypeptide monomer are provided herein, wherein the first manipulated polypeptide monomer comprises a tunable polypeptide payload and at least one drug-sensitive domain (DSD). The abundance, availability, and / or biological activity of the payload are regulated by the interaction of an effective amount of immune cell-stimulating agent with the one or more ATNF response elements and by the interaction of an effective amount of ligand with the one or more DSDs.
Need to check novelty before this filing date? Find Prior Art